Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Ketamine Hydrochloride
Therapeutic Area : Neurology
Study Phase : Undisclosed
Sponsor : Silo Pharma
Deal Size : Undisclosed
Deal Type : Agreement
Details : The joint venture will initially explore the clinical development of ketamine using ZTI’s Z-pod technology, but also provides for Silo Pharma to obtain an exclusive option for the clinical development of psilocybin using ZTI’s Z-pod technology as wel...
Product Name : Undisclosed
Product Type : Controlled Substance
Upfront Cash : Undisclosed
April 28, 2021
Lead Product(s) : Ketamine Hydrochloride
Therapeutic Area : Neurology
Highest Development Status : Undisclosed
Sponsor : Silo Pharma
Deal Size : Undisclosed
Deal Type : Agreement